Back to Browse Journals » International Journal of General Medicine » Volume 5

Autologous cord blood harvesting in North Eastern Italy: ethical questions and emerging hopes for curing diabetes and celiac disease

Authors Parco S, Vascotto F

Published Date June 2012 Volume 2012:5 Pages 511—516


Received 20 March 2012, Accepted 20 April 2012, Published 15 June 2012

Video abstract presented by Sergio Parco

Views: 58

Sergio Parco, Fulvia Vascotto

Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, Italy

Background: The Friuli Venezia Giulia (FVG), a region of North Eastern Italy, has passed legislation (Decree No 2324/2010) to regulate the banking of umbilical cord blood samples for personal, autologous, or family-directed use, and to implement the Agreement of the State-Regions Permanent Conference (Decree No 62/CSR/2010). This paper aims to identify the formalities and the reasons why families collect and bank their cord blood in foreign banks for both personal and private use.
Methods: To this end, at the Institute for Maternal and Child Health of Trieste (the regional capital city of the FVG), Italy, which assists about 1800 pregnant women a year, 129 questionnaires, drafted from January 2010 to December 2011 and concerning the granting of authorization to export samples, were examined.
Results: The collected data showed that 75% of involved families had resorted to anonymous public collection, which is available to anyone with therapeutic needs, and provided compatibility and hematologic protocols recognized by the scientific and international community (main indications: leukemia, hemoglobinopaties, and inherited hematologic and immunologic disorders). Conversely, 25.0% requested private storage at a foreign bank for personal or family-dedicated use. The principal motivation by disease was for treatment for diabetes (22.4%) and celiac disease (19.7%) (a multiorgan disease for which the FVG region has provided safeguards by approving a specific law granting support to families; Decree No 561/2007). For these two types of disease we found that information was received from the internet and not from general medical physicians, with a significant difference found using the χ2 test (P < 0.01).
Conclusion: The indication of treating these diseases with cord blood stem cell transplantation appears to be well grounded and encouraging, and has recently been corroborated by the international literature; however, the economic and social motivations promoting cord blood storage, for a fee, in the event of diseases that are still under study, require accurate information through general medical physicians on the actual possibilities of treatment.

Keywords: autologous cord blood harvesting, North Eastern Italy, emerging hopes of therapy

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Other articles by this author:

Application of reticulated platelets to transfusion management during autologous stem cell transplantation

Parco S, Vascotto F

OncoTargets and Therapy 2012, 5:1-5

Published Date: 26 January 2012

Serum anti-Müllerian hormone as a predictive marker of polycystic ovarian syndrome

Parco S, Novelli C, Vascotto F, Princi T

International Journal of General Medicine 2011, 4:759-763

Published Date: 2 November 2011

Management of immigration and pregnancy screening in northeastern Italy

Giorgio Tamaro, Sergio Parco

Risk Management and Healthcare Policy 2011, 4:9-13

Published Date: 21 January 2011

Readers of this article also read:

Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles

Orza A, Soriţău O, Tomuleasa C, Olenic L, Florea A, Pana O, Bratu I, Pall E, Florian S, Casciano D, Biris AS

International Journal of Nanomedicine 2013, 8:689-702

Published Date: 1 March 2013

Cancer stem cell theory: therapeutic implications for nanomedicine

Wang K, Wu X, Wang J, Huang J

International Journal of Nanomedicine 2013, 8:899-908

Published Date: 28 February 2013

Effects of a hybrid micro/nanorod topography-modified titanium implant on adhesion and osteogenic differentiation in rat bone marrow mesenchymal stem cells

Zhang WJ, Li ZH, Huang QF, Xu L, Li JH, Jin YQ, Wang GF, Liu XY, Jiang XQ

International Journal of Nanomedicine 2013, 8:257-265

Published Date: 11 January 2013

Autologous bone marrow cell therapy for peripheral arterial disease

Botti C, Maione C, Coppola A, Sica V, Cobellis G

Stem Cells and Cloning: Advances and Applications 2012, 5:5-14

Published Date: 6 September 2012

Sweating of Descemet's membrane during deep anterior lamellar keratoplasty in absence of perforation

Mohamed-Noriega K, Mehta JS

Clinical Ophthalmology 2012, 6:1441-1443

Published Date: 5 September 2012

Corneal reconstruction by stem cells and bioengineering

Arjamaa O

Clinical Ophthalmology 2012, 6:1407-1409

Published Date: 4 September 2012

Abdominal wall endometrioma mimicking an incarcerated hernia: a case report

Simoglou C, Zarogoulidis P, Machairiotis N, Porpodis K, Simoglou L, Mitrakas A, Esebidis A, Sarika E, Kouklakis G, Iordanidis A, Katsikogiannis N

International Journal of General Medicine 2012, 5:569-571

Published Date: 29 June 2012